Protection against pressure overload-induced right heart failure by uncoupling protein 2 silencing

被引:22
|
作者
Esfandiary, Azadeh [1 ]
Kutsche, Hanna S. [2 ]
Schreckenberg, Rolf [2 ]
Weber, Martin [2 ]
Pak, Oleg [1 ]
Kojonazarov, Baktybek [1 ]
Sydykov, Akylbek [1 ]
Hirschhaeuser, Christine [2 ]
Wolf, Annemarie [2 ]
Haag, Daniela [1 ]
Hecker, Matthias [1 ]
Fink, Ludger [1 ]
Seeger, Werner [1 ]
Ghofrani, Hossein A. [1 ]
Schermuly, Ralph T. [1 ]
Weissmann, Norbert [1 ]
Schulz, Rainer [2 ]
Rohrbach, Susanne [2 ]
Li, Ling [2 ]
Sommer, Natascha [1 ]
Schlueter, Klaus-Dieter [2 ]
机构
[1] Justus Liebig Univ Giessen, ECCPS, Aulweg 130, D-35392 Giessen, Germany
[2] Justus Liebig Univ Giessen, Dept Physiol, Aulweg 129, D-35392 Giessen, Germany
关键词
Pulmonary hypertension; Reactive oxygen species; Fibrosis; Cardiac remodelling; Cardiac protection; RAT VENTRICULAR CARDIOMYOCYTES; UCP2; INHIBITION; EXPRESSION; FIBROSIS; DISEASE;
D O I
10.1093/cvr/cvz049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The role of uncoupling protein 2 ( UCP2) in cardiac adaptation to pressure overload remains unclear. In a classical model of left ventricular pressure overload genetic deletion of UCP2 ( UCP2(-/-)) protected against cardiac hypertrophy and failure. However, in UCP2(-/-) mice increased proliferation of pulmonary arterial smooth muscle cells induces mild pulmonary hypertension, right ventricular ( RV) hypertrophy, and reduced cardiac output. This suggests a different role for UCP2 in RV and left ventricular adaptation to pressure overload. To clarify this situation in more detail UCP2(-/-) and wild-type mice were exposed to pulmonary arterial banding ( PAB). Methods and results Mice were analysed ( haemodynamics, morphometry, and echocardiography) 3 weeks after PAB or sham surgery. Myocytes and non-myocytes were isolated and analysed separately. Cell shortening of myocytes and fura-2 loading of cardiomyocytes were used to characterize their function. Brd assay was performed to study fibroblast proliferation. Isolated mitochondria were analysed to investigate the role of UCP2 for reactive oxygen species ( ROS) production. UCP2 mRNA was 2.7-fold stronger expressed in RV myocytes than in left ventricular myocytes and stronger expressed in non-myocytes compared with myocytes. Three weeks after PAB, cardiac output was reduced in wild type but preserved in UCP2(-/-) mice. UCP2(-/-) had increased RV wall thickness, but lower RV internal diameters and displayed a significant stronger fibrosis. Cardiac fibroblasts from UCP2(-/-) had reduced proliferation rates but higher collagen-1 expression. Myocytes isolated from mice after PAB banding showed preserved function that was further improved by UCP2(-/-). Mitochondrial ROS production and respiration was similar between UCP2(-/-) or wildtype hearts. Conclusion Despite a mild pulmonary hypertension in UCP2-/-mice, hearts from these mice are well preserved against additional pressure overload ( severe pulmonary hypertension). This-at least in part-depends on different behaviour of non-myocytes ( fibroblasts).
引用
收藏
页码:1217 / 1227
页数:11
相关论文
共 50 条
  • [1] Rethinking Protein Acetylation in Pressure Overload-Induced Heart Failure
    Scott, Iain
    Sack, Michael N.
    CIRCULATION RESEARCH, 2020, 127 (08) : 1109 - 1111
  • [2] Protective effect of resveratrol against pressure overload-induced heart failure
    Gupta, Prakash K.
    DiPette, Donald J.
    Supowit, Scott C.
    FOOD SCIENCE & NUTRITION, 2014, 2 (03): : 218 - 229
  • [3] Pharmacological Silencing of MicroRNA-152 Prevents Pressure Overload-Induced Heart Failure
    LaRocca, Thomas J.
    Seeger, Timon
    Prado, Maricela
    Perea-Gil, Isaac
    Neofytou, Evgenios
    Mecham, Brigham H.
    Ameen, Mohamed
    Chang, Alex Chia Yu
    Pandey, Gaurav
    Wu, Joseph C.
    Karakikes, Ioannis
    CIRCULATION-HEART FAILURE, 2020, 13 (03) : E006298
  • [4] Hypoxia Attenuates Pressure Overload-Induced Heart Failure
    Froese, Natali
    Szaroszyk, Malgorzata
    Galuppo, Paolo
    Visker, Joseph R.
    Werlein, Christopher
    Korf-Klingebiel, Mortimer
    Berliner, Dominik
    Reboll, Marc R.
    Hamouche, Rana
    Gegel, Simona
    Wang, Yong
    Hofmann, Winfried
    Tang, Ming
    Geffers, Robert
    Wende, Adam R.
    Kuehnel, Mark P.
    Jonigk, Danny D.
    Hansmann, Georg
    Wollert, Kai C.
    Abel, E. Dale
    Drakos, Stavros G.
    Bauersachs, Johann
    Riehle, Christian
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (03):
  • [5] TAURINE PROTECTION IN CALCIUM OVERLOAD-INDUCED HEART-FAILURE
    TAKIHARA, K
    AZUMA, J
    AWATA, N
    SAWAMURA, A
    HARADA, H
    OHTA, H
    HAMAGUCHI, T
    TANAKA, Y
    FUKUDA, K
    KISHIMOTO, S
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1985, 17 : 67 - 67
  • [6] LACK OF ADIPOSE TISSUE LIPOLYSIS PROTECTS AGAINST PRESSURE OVERLOAD-INDUCED HEART FAILURE
    Foryst-Ludwig, A.
    Salatzki, J.
    Brix, S.
    Ban, Z.
    Grune, J.
    Klopfleisch, R.
    Rothe, M.
    Kershaw, E.
    Kintscher, U.
    ATHEROSCLEROSIS, 2016, 252 : E259 - E259
  • [7] Rescue of Pressure Overload-Induced Heart Failure by Estrogen Therapy
    Iorga, Andrea
    Li, Jingyuan
    Sharma, Salil
    Umar, Soban
    Bopassa, Jean C.
    Nadadur, Rangarajan D.
    Centala, Alexander
    Ren, Shuxun
    Saito, Tomoaki
    Toro, Ligia
    Wang, Yibin
    Stefani, Enrico
    Eghbali, Mansoureh
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (01): : 1 - 12
  • [8] Effects of Pitavastatin on Pressure Overload-Induced Heart Failure in Mice
    Kameda, Yoshihito
    Hasegawa, Hiroshi
    Kubota, Akihiko
    Tadokoro, Hiroyuki
    Kobayashi, Yoshio
    Komuro, Issei
    Takano, Hiroyuki
    CIRCULATION JOURNAL, 2012, 76 (05) : 1159 - 1168
  • [9] EFFECT OF PITAVASTATIN ON PRESSURE OVERLOAD-INDUCED HEART FAILURE IN MICE
    Kameda, Yoshihito
    Hasegawa, Hiroshi
    Kubota, Akihiko
    Tadokoro, Hiroyuki
    Kobayashi, Yoshio
    Takano, Hiroyuki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1062 - E1062
  • [10] The Raf kinase inhibitor protein protects from pressure overload-induced heart failure
    Lorenz, K.
    Schmid, E.
    Berlin, C.
    Kahlert, K.
    Schmitt, J. P.
    Lohse, M. J.
    EUROPEAN HEART JOURNAL, 2014, 35 : 553 - 554